Health Care Biotech and Pharmaceuticals

• Health Care
• Hospitals
• Pharma
• Health Insurance
• Modern Medicine

More

• Amgen posts higher first quarter profit as sales rise 3 percent

  8:44 AM ET Wed, 25 April 2018

  The drugmaker's profits were driven by lower taxes and an increase in product sales of newer drugs.

• See headwinds drifting in from 2017: Novozymes   

  4:41 AM ET Wed, 25 April 2018

  Chief executive Peder Holk Nielsen speaks about earnings, adding that his business sees risk primarily in the agricultural sector.

• Takeda finally lands Shire for $64 billion in the biggest pharma deal of the year

  5:49 AM ET Wed, 25 April 2018

  Rare disease drug maker Shire Plc said it was willing to recommend a sweetened offer from Japan's Takeda Pharmaceutical Co to shareholders.

• Biotech firms likely to apply for listing in Hong Kong soon: PwC Hong Kong   

  3:03 AM ET Wed, 25 April 2018

  New listing rules for Hong Kong's stock exchange may result in some new biotech listing applications coming as early as May, says Benson Wong of PwC Hong Kong.

• Discussing the HKEX's new listing rules   

  12:45 AM ET Wed, 25 April 2018

  Investors are looking for bigger tech names to list on Hong Kong's stock exchange under the new rules, says Irene Chu of KPMG China.

• Why the HKEX is wooing biotech firms: CEO   

  9:30 PM ET Tue, 24 April 2018

  Charles Li of Hong Kong Exchanges and Clearing says access to capital is critical for highly-regulated companies developing drugs.

• Shire, Takeda reach breakthrough in merger talks, says Reuters   

  7:01 PM ET Tue, 24 April 2018

  CNBC's Meg Tirrell reports on Shire and Takeda reaching a breakthrough in merger talks according to Reuters.

• Biogen revenue climbs, while Spinraza, Tecfidera sales miss

  8:01 AM ET Tue, 24 April 2018

  Drug developer Biogen reported a 11.4 percent rise in quarterly revenue as sales of key drugs Tecfidera and Spinraza climbed, albeit at a weaker-than-expected pace.

• Eli Lilly beats earnings expectations, boosts outlook after regulatory setback

  5:00 PM ET Tue, 24 April 2018

  A Food and Drug Administration panel advised on Monday against a high dose of Lilly-Incyte's rheumatoid arthritis drug while voting in favor of the lower dose.

• Fight brews over Shkreli's Wu-Tang album as 'pharma bro' gets banned by securities industry

  7:30 PM ET Mon, 23 April 2018

  New York's attorney general said state tax authorities are entitled to first dibs on more than $480,000 out of the nearly $7.4 million Shkreli was ordered to forfeit as regulators reveal Shrkreli had agreed to be barred from the securities industry.

• You can get rid of your unused medications at these drugstores

  11 Hours Ago

  If you have leftover pain pills or other prescription drugs, you should get rid of them. Drugstore chains Walgreens and CVS Health are adding kiosks in some of their stores to make it easier.

• Goldman upgrades Merck, calls it one of its top stocks, cites Keytruda lung cancer breakthrough

  8:45 AM ET Mon, 23 April 2018

  Goldman Sachs upgrades Merck to buy from neutral.

• Fresenius shares rally after it ditches Akorn takeover

  6:32 AM ET Mon, 23 April 2018

  German health-care group Fresenius said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drugmaker.

• Takeda increases bid for Shire   

  11:29 AM ET Fri, 20 April 2018

  CNBC’s David Faber reports that Japanese drug company Takeda is increasing its proposal for Shire.

• Johnson & Johnson is betting on vision care and expanding beyond contacts

  10:40 AM ET Fri, 20 April 2018

  J&J has added surgical products and a contact subscription service to its lineup of Acuvue contact lenses.

• FDA commissioner to drug middlemen: You're part of the problem

  4:25 PM ET Thu, 19 April 2018

  Drug manufacturers are using several schemes to "hamstring biosimilar competition," and FDA Commissioner Scott Gottlieb worries pharmacy benefit managers have been "complacent participants" in them.